About Promea Therapeutics
Promea Therapeutics is a company based in Patancheruvu (India) founded in 2017 by Pooja Aakanksha Gaddam and Rajesh Tummuru. The company has 174 employees as of April 06, 2024. Promea Therapeutics operates in a competitive market with competitors including GE Healthcare, Medtronic, Boston Scientific, Baxter and CONMED, among others.
- Headquarter Patancheruvu, India
- Employees 174 as on 06 Apr, 2024
- Founders Pooja Aakanksha Gaddam, Rajesh Tummuru
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Promea Therapeutics Private Limited
- Date of Incorporation 31 Jul, 2017
- Jurisdiction Patancheru, Telangana, India
-
Annual Revenue
$6.83 M (USD)98.06as on Mar 31, 2023
-
Net Profit
-$140.42 K (USD)-17198.9as on Mar 31, 2023
-
EBITDA
$1.37 M (USD)225.23as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
174
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Promea Therapeutics
Unlock access to complete
Funding Insights of Promea Therapeutics
Detailed funding history for Promea Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Promea Therapeutics
Investment portfolio details for Promea Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Promea Therapeutics
Detailed financials for Promea Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Promea Therapeutics Comparisons
Peer comparison for Promea Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Promea Therapeutics
Promea Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GE Healthcare, Medtronic, Boston Scientific, Baxter and CONMED, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Materials management solutions are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| Locked | Locked | Locked |
Wide range of medical devices
|
|
| Locked | Locked | Locked |
Biosciences, medication delivery, and renal products are developed and marketed.
|
|
| Locked | Locked | Locked |
Surgical instruments are manufactured for multiple therapeutic areas.
|
|
| Locked | Locked | Locked |
Healthcare solutions are provided by Johnson & Johnson globally.
|
Detailed competitors of Promea Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Promea Therapeutics
Complete news archive for Promea Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Promea Therapeutics
Promea Therapeutics was founded in 2017.
Promea Therapeutics is headquartered in Patancheruvu, India. It is registered at Patancheruvu, Telangana, India.
As of Apr 06, 2024, the latest employee count at Promea Therapeutics is 174.
Annual revenue of Promea Therapeutics is $6.83M as on Mar 31, 2023.
Promea Therapeutics was founded in 2017 and is based in Patancheruvu, India. Operations focus on the production of medical products within the life sciences sector, including diagnostics for clinical chemistry, immunodiagnostics, and molecular diagnostics, as well as infusion therapies. These offerings support healthcare applications through established manufacturing processes in the region.
Promea Therapeutics's top competitors include GE Healthcare, Medtronic and Boston Scientific.